Pawel Namsolleck

2.5k total citations
35 papers, 1.5k citations indexed

About

Pawel Namsolleck is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pawel Namsolleck has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pawel Namsolleck's work include Receptor Mechanisms and Signaling (12 papers), Renin-Angiotensin System Studies (12 papers) and Hormonal Regulation and Hypertension (7 papers). Pawel Namsolleck is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Renin-Angiotensin System Studies (12 papers) and Hormonal Regulation and Hypertension (7 papers). Pawel Namsolleck collaborates with scholars based in Germany, Netherlands and Denmark. Pawel Namsolleck's co-authors include Thomas Unger, U. Muscha Steckelings, Elena Kaschina, Ludovít Paulis, Michaël Blaut, Sébastien Foulquier, Matthew Collins, Kim Holmstrøm, Mirjana Rajilić–Stojanović and Kristin Lucht and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Diabetes.

In The Last Decade

Pawel Namsolleck

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pawel Namsolleck Germany 20 653 538 378 232 162 35 1.5k
Éric Rousseau Canada 29 798 1.2× 291 0.5× 192 0.5× 490 2.1× 159 1.0× 90 2.1k
Andréia Carvalho Alzamora Brazil 17 281 0.4× 584 1.1× 349 0.9× 257 1.1× 65 0.4× 36 1.4k
Thibaut Duparc France 21 947 1.5× 206 0.4× 291 0.8× 789 3.4× 160 1.0× 39 2.0k
Sabine Kossmann Germany 20 681 1.0× 619 1.2× 339 0.9× 575 2.5× 71 0.4× 36 2.3k
Lucienne S. Lara Brazil 26 809 1.2× 699 1.3× 552 1.5× 135 0.6× 86 0.5× 64 1.6k
Luciano dos Santos Aggum Capettini Brazil 20 511 0.8× 285 0.5× 158 0.4× 488 2.1× 62 0.4× 59 1.5k
Daisy Motta‐Santos Brazil 20 377 0.6× 712 1.3× 267 0.7× 287 1.2× 95 0.6× 53 1.8k
Joyce B. Harp United States 26 750 1.1× 349 0.6× 538 1.4× 749 3.2× 96 0.6× 39 2.4k
Lourdes Garrido‐Sánchez Spain 26 452 0.7× 325 0.6× 285 0.8× 681 2.9× 50 0.3× 79 1.8k
Masataka Kusunoki Japan 21 381 0.6× 147 0.3× 379 1.0× 417 1.8× 111 0.7× 80 1.3k

Countries citing papers authored by Pawel Namsolleck

Since Specialization
Citations

This map shows the geographic impact of Pawel Namsolleck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pawel Namsolleck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pawel Namsolleck more than expected).

Fields of papers citing papers by Pawel Namsolleck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pawel Namsolleck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pawel Namsolleck. The network helps show where Pawel Namsolleck may publish in the future.

Co-authorship network of co-authors of Pawel Namsolleck

This figure shows the co-authorship network connecting the top 25 collaborators of Pawel Namsolleck. A scholar is included among the top collaborators of Pawel Namsolleck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pawel Namsolleck. Pawel Namsolleck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namsolleck, Pawel, Barbara Kofler, & Gert N. Moll. (2023). Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 24(12). 10193–10193. 4 indexed citations
2.
Namsolleck, Pawel, et al.. (2023). LP2, a stable lanthipeptide derived from cAng‐(1‐7), exerts myeloprotective action in mice. European Journal Of Haematology. 110(5). 534–539. 2 indexed citations
3.
Villela, Daniel Campos, Pawel Namsolleck, Christoph Reichetzeder, & Gert N. Moll. (2023). AT2 receptor agonist LP2 restores respiratory function in a rat model of bleomycin-induced lung remodelling. Peptides. 170. 171106–171106. 1 indexed citations
5.
Sommerfeld, Manuela, et al.. (2018). AT 2 R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat. Hypertension. 72(3). e20–e29. 27 indexed citations
6.
Foulquier, Sébastien, Pawel Namsolleck, Irina V. Milanova, et al.. (2018). Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice. Hypertension Research. 41(10). 817–827. 38 indexed citations
7.
Kaschina, Elena, Pawel Namsolleck, & Thomas Unger. (2017). AT2 receptors in cardiovascular and renal diseases. Pharmacological Research. 125(Pt A). 39–47. 92 indexed citations
8.
Paulis, Ludovít, Sébastien Foulquier, Pawel Namsolleck, et al.. (2015). Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders. Drugs. 76(1). 1–12. 30 indexed citations
9.
Namsolleck, Pawel, et al.. (2014). Aldosterone synthase inhibitors in cardiovascular and renal diseases. Nephrology Dialysis Transplantation. 29(suppl 1). i62–i68. 51 indexed citations
10.
Namsolleck, Pawel, Chiara Recarti, Sébastien Foulquier, U. Muscha Steckelings, & Thomas Unger. (2014). AT2 Receptor and Tissue Injury: Therapeutic Implications. Current Hypertension Reports. 16(2). 416–416. 81 indexed citations
11.
Namsolleck, Pawel, Francesco Boato, Ludovít Paulis, et al.. (2012). AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiology of Disease. 51. 177–191. 71 indexed citations
12.
Thöne‐Reineke, Christa, Maxim Krikov, Michael Godes, et al.. (2011). Prevention and Intervention Studies with Telmisartan, Ramipril and Their Combination in Different Rat Stroke Models. PLoS ONE. 6(8). e23646–e23646. 31 indexed citations
13.
Thöne‐Reineke, Christa, Kristin Lucht, Pawel Namsolleck, et al.. (2011). DIRECT ANGIOTENSIN AT2-RECEPTOR STIMULATION IMPROVES SURVIVAL AND NEUROLOGICAL OUTCOME IN EXPERIMENTAL STROKE (MCAO) IN MICE. Journal of Hypertension. 29. e50–e51. 2 indexed citations
14.
Benz, Verena, Markus Clemenz, Anna Foryst‐Ludwig, et al.. (2011). Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis. Diabetes. 61(2). 513–523. 70 indexed citations
15.
Steckelings, U. Muscha, Mats Larhed, Anders Hallberg, et al.. (2010). Non-peptide AT2-receptor agonists. Current Opinion in Pharmacology. 11(2). 187–192. 84 indexed citations
16.
Thöne‐Reineke, Christa, Christian Neumann, Pawel Namsolleck, et al.. (2008). The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. Journal of Hypertension. 26(12). 2426–2435. 90 indexed citations
17.
Mohan, Ruchika, Pawel Namsolleck, Paul A. Lawson, et al.. (2005). Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Systematic and Applied Microbiology. 29(4). 292–299. 25 indexed citations
18.
Weickert, Martin O., Matthias Möhlig, Corinna Koebnick, et al.. (2005). Impact of cereal fibre on glucose-regulating factors. Diabetologia. 48(11). 2343–2353. 141 indexed citations
19.
Namsolleck, Pawel, et al.. (2004). Solubilizing poorly soluble antimy cotic agents by emulsification via a solvenent-free process. AAPS PharmSciTech. 5(1). 159–164. 19 indexed citations
20.
Namsolleck, Pawel, Paul A. Lawson, Kim Holmstrøm, et al.. (2004). Molecular methods for the analysis of gut microbiota. Microbial Ecology in Health and Disease. 16(2-3). 71–85. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026